First case of immune-mediated haemolytic anaemia associated to imatinib mesylate
Author:
Publisher
Wiley
Subject
Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.0902-4441.2003.00128.x/fullpdf
Reference13 articles.
1. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia;Druker;N Engl J Med,2001
2. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumors: a phase I study;Oosterom;Lancet,2001
3. Events after imatinib mesylate therapy;Elliott;N Engl J Med,2002
4. Cerebral oedema as a possible complication of treatment with imatinib;Ebnoether;Lancet,2002
5. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia;Kantarjian;New Engl J Med,2002
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Autoimmune Hemolytic Anemia After Relapse of Chronic Myeloid Leukemia: A Case Report;Clinical Medicine Insights: Blood Disorders;2019-01
2. Differential interactions of imatinib mesylate with the membrane skeletal protein spectrin and hemoglobin;RSC Advances;2016
3. Drug-induced immune thrombocytopenia associated with use of tyrosine kinase inhibitor imatinib;Journal of Taibah University Medical Sciences;2015-09
4. Incidence of persistent/late chronic anemia in newly diagnosed patients with chronic myeloid leukemia responsive to imatinib;American Journal of Hematology;2014-11-19
5. Anémie hémolytique sous traitement par erlotinib;Revue de Pneumologie Clinique;2013-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3